Volonté MA - Search Results

1

Iron chelation in early Parkinson's disease.

Levi S, Volonté MA. Levi S, et al. Among authors: volonte ma. Lancet Neurol. 2023 Apr;22(4):290-291. doi: 10.1016/S1474-4422(23)00039-X. Lancet Neurol. 2023. PMID: 36931794 No abstract available.

2

Genotoxic damage induced by doxorubicin in two human melanoma cell lines.

Dolfini E, Bianchi E, Ubezio P, Volontè M, Fuhrman Conti AM. Dolfini E, et al. Cytotechnology. 1987 Oct;1(1):95-7. doi: 10.1007/BF00351132. Cytotechnology. 1987. PMID: 22358450 No abstract available.

3

Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy.

Spagnolo F, Ceppi D, Cardamone R, Falautano M, Martinelli V, Comi G, Perani D, Volonté MA. Spagnolo F, et al. Among authors: volonte ma. Mov Disord. 2011 Sep;26(11):2131-2. doi: 10.1002/mds.23768. Epub 2011 May 25. Mov Disord. 2011. PMID: 21618283 No abstract available.

4

Effect of haloperidol and clozapine on (+)SKF 10,047-induced dopamine release: role of 5-HT3 receptors.

Volonté M, Ceci A, Borsini F. Volonté M, et al. Eur J Pharmacol. 1992 Mar 17;213(1):163-4. doi: 10.1016/0014-2999(92)90250-8. Eur J Pharmacol. 1992. PMID: 1499654

5

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.

Volonté M, Monferini E, Cerutti M, Fodritto F, Borsini F. Volonté M, et al. J Neurochem. 1997 Jul;69(1):182-90. doi: 10.1046/j.1471-4159.1997.69010182.x. J Neurochem. 1997. PMID: 9202309 Free article.

6

Focal task-specific tremors.

Soland VL, Bhatia KP, Volonte MA, Marsden CD. Soland VL, et al. Among authors: volonte ma. Mov Disord. 1996 Nov;11(6):665-70. doi: 10.1002/mds.870110611. Mov Disord. 1996. PMID: 8914092

7

Dipsogenic-like and behavioural effects of bombesin administered intracerebroventricularly to sheep.

Belloli C, Beretta C, Marchisio A, Ormas P, Tanzi GB, Volonte' M. Belloli C, et al. J Vet Pharmacol Ther. 1987 Sep;10(3):210-7. doi: 10.1111/j.1365-2885.1987.tb00531.x. J Vet Pharmacol Ther. 1987. PMID: 3656507

8

New CCK antagonists derived from the amino acid residues of the CCK-8 fragment.

Cereda E, Bellora E, Ezhayra A, Monferini E, Schiavone A, Volontè M, Donetti A. Cereda E, et al. Farmaco. 1991 Jan;46(1):45-62. Farmaco. 1991. PMID: 2054041

9

Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study.

Volonté M, Ceci A, Borsini F. Volonté M, et al. J Pharmacol Exp Ther. 1995 Oct;275(1):358-67. J Pharmacol Exp Ther. 1995. PMID: 7562571

10

The gastrointestinal motor effect of benzamide derivatives is unrelated to 5-HT3 receptor blockade.

Schiavone A, Volonté M, Micheletti R. Schiavone A, et al. Eur J Pharmacol. 1990 Oct 23;187(3):323-9. doi: 10.1016/0014-2999(90)90359-e. Eur J Pharmacol. 1990. PMID: 2073919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page